vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and TREX CO INC (TREX). Click either name above to swap in a different company.
TREX CO INC is the larger business by last-quarter revenue ($343.4M vs $268.1M, roughly 1.3× ACADIA PHARMACEUTICALS INC). TREX CO INC runs the higher net margin — 17.9% vs 1.4%, a 16.5% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs 1.0%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -4.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Trex Company, Inc. is a manufacturer of wood-alternative composite decking, residential railing, and other outdoor items made from recycled materials. Its headquarters is in Winchester, Virginia.
ACAD vs TREX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $343.4M |
| Net Profit | $3.6M | $61.4M |
| Gross Margin | — | 40.5% |
| Operating Margin | -1.7% | 24.3% |
| Net Margin | 1.4% | 17.9% |
| Revenue YoY | 9.7% | 1.0% |
| Net Profit YoY | — | 1.6% |
| EPS (diluted) | $0.02 | $0.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $343.4M | ||
| Q4 25 | $284.0M | $161.1M | ||
| Q3 25 | $278.6M | $285.3M | ||
| Q2 25 | $264.6M | $387.8M | ||
| Q1 25 | $244.3M | $340.0M | ||
| Q4 24 | $259.6M | $167.6M | ||
| Q3 24 | $250.4M | $233.7M | ||
| Q2 24 | $242.0M | $376.5M |
| Q1 26 | $3.6M | $61.4M | ||
| Q4 25 | $273.6M | $2.3M | ||
| Q3 25 | $71.8M | $51.8M | ||
| Q2 25 | $26.7M | $75.9M | ||
| Q1 25 | $19.0M | $60.4M | ||
| Q4 24 | $143.7M | $9.8M | ||
| Q3 24 | $32.8M | $40.6M | ||
| Q2 24 | $33.4M | $87.0M |
| Q1 26 | — | 40.5% | ||
| Q4 25 | 90.8% | 30.2% | ||
| Q3 25 | 92.2% | 40.5% | ||
| Q2 25 | 92.2% | 40.8% | ||
| Q1 25 | 91.7% | 40.5% | ||
| Q4 24 | 91.6% | 32.7% | ||
| Q3 24 | 92.5% | 39.9% | ||
| Q2 24 | 92.5% | 44.7% |
| Q1 26 | -1.7% | 24.3% | ||
| Q4 25 | 6.1% | 2.2% | ||
| Q3 25 | 12.8% | 24.7% | ||
| Q2 25 | 12.2% | 26.4% | ||
| Q1 25 | 7.9% | 24.0% | ||
| Q4 24 | 59.1% | 9.2% | ||
| Q3 24 | 12.6% | 23.2% | ||
| Q2 24 | 12.6% | 31.1% |
| Q1 26 | 1.4% | 17.9% | ||
| Q4 25 | 96.3% | 1.4% | ||
| Q3 25 | 25.8% | 18.1% | ||
| Q2 25 | 10.1% | 19.6% | ||
| Q1 25 | 7.8% | 17.8% | ||
| Q4 24 | 55.4% | 5.8% | ||
| Q3 24 | 13.1% | 17.4% | ||
| Q2 24 | 13.8% | 23.1% |
| Q1 26 | $0.02 | $0.58 | ||
| Q4 25 | $1.61 | $0.03 | ||
| Q3 25 | $0.42 | $0.48 | ||
| Q2 25 | $0.16 | $0.71 | ||
| Q1 25 | $0.11 | $0.56 | ||
| Q4 24 | $0.86 | $0.10 | ||
| Q3 24 | $0.20 | $0.37 | ||
| Q2 24 | $0.20 | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $995.8M |
| Total Assets | $1.6B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $4.5M | ||
| Q4 25 | $177.7M | $3.8M | ||
| Q3 25 | $258.0M | $11.4M | ||
| Q2 25 | $253.6M | $5.5M | ||
| Q1 25 | $217.7M | $5.0M | ||
| Q4 24 | $319.6M | $1.3M | ||
| Q3 24 | $155.1M | $12.8M | ||
| Q2 24 | $177.1M | $1.2M |
| Q1 26 | — | $995.8M | ||
| Q4 25 | $1.2B | $1.0B | ||
| Q3 25 | $917.3M | $1.0B | ||
| Q2 25 | $822.4M | $989.3M | ||
| Q1 25 | $765.2M | $910.1M | ||
| Q4 24 | $732.8M | $850.1M | ||
| Q3 24 | $577.2M | $887.9M | ||
| Q2 24 | $516.7M | $894.9M |
| Q1 26 | $1.6B | $1.7B | ||
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.2B | $1.5B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $976.9M | $1.3B | ||
| Q2 24 | $914.1M | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-118.4M |
| Free Cash FlowOCF − Capex | — | $-143.4M |
| FCF MarginFCF / Revenue | — | -41.8% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -1.93× |
| TTM Free Cash FlowTrailing 4 quarters | — | $224.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-118.4M | ||
| Q4 25 | $-48.7M | $65.5M | ||
| Q3 25 | $74.3M | $196.9M | ||
| Q2 25 | $64.0M | $249.8M | ||
| Q1 25 | $20.3M | $-154.0M | ||
| Q4 24 | $40.4M | $-8.5M | ||
| Q3 24 | $63.2M | $132.8M | ||
| Q2 24 | $25.0M | $193.7M |
| Q1 26 | — | $-143.4M | ||
| Q4 25 | — | $22.1M | ||
| Q3 25 | $73.9M | $142.9M | ||
| Q2 25 | — | $203.0M | ||
| Q1 25 | — | $-233.5M | ||
| Q4 24 | — | $-89.3M | ||
| Q3 24 | $63.2M | $54.5M | ||
| Q2 24 | — | $158.2M |
| Q1 26 | — | -41.8% | ||
| Q4 25 | — | 13.7% | ||
| Q3 25 | 26.5% | 50.1% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | -68.7% | ||
| Q4 24 | — | -53.3% | ||
| Q3 24 | 25.2% | 23.3% | ||
| Q2 24 | — | 42.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 26.9% | ||
| Q3 25 | 0.1% | 18.9% | ||
| Q2 25 | — | 12.1% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | 0.0% | 33.5% | ||
| Q2 24 | — | 9.4% |
| Q1 26 | — | -1.93× | ||
| Q4 25 | -0.18× | 28.45× | ||
| Q3 25 | 1.03× | 3.80× | ||
| Q2 25 | 2.40× | 3.29× | ||
| Q1 25 | 1.07× | -2.55× | ||
| Q4 24 | 0.28× | -0.87× | ||
| Q3 24 | 1.93× | 3.27× | ||
| Q2 24 | 0.75× | 2.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
